Clinical Trials Logo

Fatigue Syndrome, Chronic clinical trials

View clinical trials related to Fatigue Syndrome, Chronic.

Filter by:

NCT ID: NCT01893619 Recruiting - Clinical trials for Chronic Fatigue Syndrome

Observational Research on Use of Immunoprop Supplement in Chronic Fatigue Syndrome

immunoprop
Start date: June 2013
Phase: N/A
Study type: Observational

Observational study regarding the use of supplements in chronic fatigue syndrome patients

NCT ID: NCT01873482 Completed - Depression Clinical Trials

Traditional African Healing Ceremony in a U.S. Population

Start date: May 2014
Phase: N/A
Study type: Interventional

Pre-agricultural societies almost universally used healing ceremonies that involved reverence, rhythm and dance in the presence of a healer. It is believed that we are "wired" for such experiences and they foster an integrative mode of consciousness similar to that of mindfulness based stress reduction, which has been shown to have therapeutic effects in a variety of conditions. Collaborator Ava Lavonne Vinesett of the Duke Dance Program has developed a healing ceremony based in sub-Saharan African traditions. The investigators plan is to have 25 subjects with a variety of clinical conditions participate in this ceremony. Subjects will then be asked to write a commentary about their experience and to participate in a focus group discussion. It is anticipated that the study will give us some idea of how promising this approach would be and what kinds of patients might benefit. Safety issues are minimal and include the possibility of injury (though the dancing is not strenuous) and psychological distress.

NCT ID: NCT01872351 Withdrawn - Clinical trials for Chronic Fatigue Syndrome

Therapy for Chronic Fatigue Syndrome: A Presumptive Mitochondrial Disorder

Start date: November 2011
Phase: Phase 1
Study type: Observational

The purpose of this study is to determine whether therapy that has been shown to be beneficial for mitochondrial diseases is also beneficial for Chronic Fatigue Syndrome (CFS) patients. This study is a chart review of previous CFS patients who received daily conditioning exercise, a high protein diet and nutraceutical therapy (ENT). Prescribed nutraceutical supplements included alpha-lipoic acid, acetyl-L-carnitine, omega-3fatty acids (maxDHA), coenzyme Q10 (CoQ10), plus a multivitamin. Twelve CFS male and female patients between the ages of 20-70 years will be recruited to participate in this pilot study. Subjects will be eligible to participate if they meet the criteria for CFS of the Centers for Disease Control and Prevention (CDC). These include persistent, unexplained fatigue for at least 6 months, concurrent with four of the following: impaired memory/concentration, sore throat, new headaches, unrefreshing sleep, muscle pain, multi-joint pain, tender lymph nodes, and post-exertional malaise.

NCT ID: NCT01806246 Completed - Clinical trials for Chronic Fatigue Syndrome

A Rehabilitation Program for Adolescents With Chronic Fatigue Syndrome

Start date: February 2013
Phase: N/A
Study type: Interventional

The aim of the programme is to develop a treatment model for adolescents with Chronic Fatigue Syndrome. The program consists of 4 elements lasting for 12 months, psychoeducation reflecting the current knowledge about the disease, Heart Rate Variability Coherence Biofeedback, pacing and activity planning and some principles of cognitive behaviour therapy. The study is designed as a Single-Case study including 10- 15 participants.

NCT ID: NCT01793415 Recruiting - Clinical trials for Chronic Fatigue Syndrome

Treatment of Chronic Fatigue Syndrome (CFS) With Iodinated Activated Charcoal (IodoCarb®)

Start date: February 2013
Phase: Phase 1/Phase 2
Study type: Interventional

Chronic fatigue syndrome (CFS) is a devastating and complex disorder. People with CFS experience overwhelming fatigue and a host of other symptoms that are not improved by bed rest. Interestingly, many of the symptoms experienced by people with CFS are identical to symptoms caused by long-term low-level exposure to mercury, which is called micromercurialism. This study will examine if the mercury binding substance IodoCarb(r) can improve the health of patients with CFS.

NCT ID: NCT01765725 Completed - Clinical trials for Chronic Fatigue Syndrome

Coping With Chronic Fatigue Syndrome: Development of a Community-based Patient Education Program

Start date: April 2011
Phase: N/A
Study type: Interventional

The aim of the study is to develop, carry out, evaluate and measure the effects of a new patient education program for patients with Chronic Fatigue Syndrome (CFS)in primary healthcare. In an randomized controlled trial design the effects of the patient education program on coping, physical functioning, fatigue, pain, acceptance, anxiety, depression, quality of life, self- efficacy, and illness perception will be compared with treatment as usual. The results of the main project will lead to the elaboration of the final patient education program that can be implemented in primary health care, as well as development of a training program for future program-conductors.

NCT ID: NCT01742013 Completed - Clinical trials for Chronic Fatigue Syndrome

Investigator Initiated Clinical Study to Explore the Efficacy and Safety of Human Placenta Hydrolysate in the Chronic Fatigue Patients

Start date: January 2013
Phase: Phase 3
Study type: Interventional

GCJBP Laennec Injection contains a variety of cytokines derived from human placenta, amino acids, peptides, nucleobases, and carbohydrates. This product is approved for improving liver function. Also, it has been prescribed for lots of diseases such as menopausal disorders, atopic dermatitis, skin cares as well as fatigue for long time. Although its action mechanism and clinical effectiveness are not still clear, there are reports which say a strong probability of its clinical effectiveness in the chronic fatigue patients. This study aims to investigate the safety and efficacy of GCJBP Laennec Inj. (Human placenta hydrolysate) in the chronic fatigue patients through a randomized controlled tial.

NCT ID: NCT01730495 Terminated - Clinical trials for Chronic Fatigue Syndrome

Tumor Necrosis Factor-alpha Inhibition Using Etanercept in Chronic Fatigue Syndrome

Start date: October 2012
Phase: Phase 2
Study type: Interventional

The hypothesis is that a subset of patients with chronic fatigue syndrome/ myalgic encephalomyelitis (CFS/ME), including also patients with no clinical response after B-cell depletion therapy using the anti-CD20 antibody Rituximab, may benefit from tumor necrosis factor-alpha inhibition using Etanercept as weekly subcutaneous injections.

NCT ID: NCT01689467 Completed - Clinical trials for Chronic Fatigue Syndrome

Efficacy and Safety of Fermented Velvet Antler Extract on Fatigue Recovery After Exercise

Start date: April 25, 2013
Phase: N/A
Study type: Interventional

The investigators performed a 12-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Fermented Velvet Antler extract on fatigue recovery after exercise. The investigators measured fatigue recovery parameters , including lactate, ammonia, inorganic phosphorus, creatine kinase and LDH, and monitored their blood pressure.

NCT ID: NCT01686074 Completed - Fibromyalgia Clinical Trials

Motor Control in Chronic Fatigue Syndrome and Fibromyalgia

Start date: September 2012
Phase: N/A
Study type: Observational

This project is a comprehensive study, with main focus on motor control, comparing patients with chronic fatigue syndrome / myalgic encephalopathy (CFS/ME) and/or fibromyalgia syndrome (FMS). Focus of the present project will be on detailed movement analysis in a movement laboratory and involve functional tasks such as walking and standing. Investigations will also comprise muscle activity, reaction time and fine motor control.